Abstract
Summary
Pharmaceuticals plant proteins are derived from plants and utilized in the development and production of various medicinal and therapeutic products. These proteins are valued for their potential in creating biopharmaceuticals, including vaccines, antibodies, and enzymes, due to their ability to be produced in large quantities with relatively low cost and high safety profiles. They are engineered using plant-based systems such as tobacco, rice, and algae, which can be genetically modified to produce the desired protein.
The global Pharmaceuticals Plant Protein market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceuticals Plant Protein Industry Forecast” looks at past sales and reviews total world Pharmaceuticals Plant Protein sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceuticals Plant Protein sales for 2024 through 2030. With Pharmaceuticals Plant Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceuticals Plant Protein industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceuticals Plant Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceuticals Plant Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceuticals Plant Protein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceuticals Plant Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceuticals Plant Protein.
United States market for Pharmaceuticals Plant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceuticals Plant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceuticals Plant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceuticals Plant Protein players cover ADM, Cargill, DuPont, Kerry Group, Manildra, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceuticals Plant Protein market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Soy Protein
Wheat Protein
Pea Protein
Others
Segmentation by Application:
Dietary Supplements
Medicinal Protein
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ADM
Cargill
DuPont
Kerry Group
Manildra
Roquette
Tereos
Axiom Foods
Cosucra
CHS
Glanbia Nutritionals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceuticals Plant Protein market?
What factors are driving Pharmaceuticals Plant Protein market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceuticals Plant Protein market opportunities vary by end market size?
How does Pharmaceuticals Plant Protein break out by Type, by Application?
The global Pharmaceuticals Plant Protein market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceuticals Plant Protein Industry Forecast” looks at past sales and reviews total world Pharmaceuticals Plant Protein sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceuticals Plant Protein sales for 2024 through 2030. With Pharmaceuticals Plant Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceuticals Plant Protein industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceuticals Plant Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceuticals Plant Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceuticals Plant Protein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceuticals Plant Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceuticals Plant Protein.
United States market for Pharmaceuticals Plant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceuticals Plant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceuticals Plant Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceuticals Plant Protein players cover ADM, Cargill, DuPont, Kerry Group, Manildra, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceuticals Plant Protein market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Soy Protein
Wheat Protein
Pea Protein
Others
Segmentation by Application:
Dietary Supplements
Medicinal Protein
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ADM
Cargill
DuPont
Kerry Group
Manildra
Roquette
Tereos
Axiom Foods
Cosucra
CHS
Glanbia Nutritionals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceuticals Plant Protein market?
What factors are driving Pharmaceuticals Plant Protein market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceuticals Plant Protein market opportunities vary by end market size?
How does Pharmaceuticals Plant Protein break out by Type, by Application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceuticals Plant Protein Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pharmaceuticals Plant Protein by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pharmaceuticals Plant Protein by Country/Region, 2019, 2023 & 2030
2.2 Pharmaceuticals Plant Protein Segment by Type
2.2.1 Soy Protein
2.2.2 Wheat Protein
2.2.3 Pea Protein
2.2.4 Others
2.3 Pharmaceuticals Plant Protein Sales by Type
2.3.1 Global Pharmaceuticals Plant Protein Sales Market Share by Type (2019-2024)
2.3.2 Global Pharmaceuticals Plant Protein Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pharmaceuticals Plant Protein Sale Price by Type (2019-2024)
2.4 Pharmaceuticals Plant Protein Segment by Application
2.4.1 Dietary Supplements
2.4.2 Medicinal Protein
2.4.3 Others
2.5 Pharmaceuticals Plant Protein Sales by Application
2.5.1 Global Pharmaceuticals Plant Protein Sale Market Share by Application (2019-2024)
2.5.2 Global Pharmaceuticals Plant Protein Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pharmaceuticals Plant Protein Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Pharmaceuticals Plant Protein Breakdown Data by Company
3.1.1 Global Pharmaceuticals Plant Protein Annual Sales by Company (2019-2024)
3.1.2 Global Pharmaceuticals Plant Protein Sales Market Share by Company (2019-2024)
3.2 Global Pharmaceuticals Plant Protein Annual Revenue by Company (2019-2024)
3.2.1 Global Pharmaceuticals Plant Protein Revenue by Company (2019-2024)
3.2.2 Global Pharmaceuticals Plant Protein Revenue Market Share by Company (2019-2024)
3.3 Global Pharmaceuticals Plant Protein Sale Price by Company
3.4 Key Manufacturers Pharmaceuticals Plant Protein Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceuticals Plant Protein Product Location Distribution
3.4.2 Players Pharmaceuticals Plant Protein Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pharmaceuticals Plant Protein by Geographic Region
4.1 World Historic Pharmaceuticals Plant Protein Market Size by Geographic Region (2019-2024)
4.1.1 Global Pharmaceuticals Plant Protein Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pharmaceuticals Plant Protein Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pharmaceuticals Plant Protein Market Size by Country/Region (2019-2024)
4.2.1 Global Pharmaceuticals Plant Protein Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pharmaceuticals Plant Protein Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharmaceuticals Plant Protein Sales Growth
4.4 APAC Pharmaceuticals Plant Protein Sales Growth
4.5 Europe Pharmaceuticals Plant Protein Sales Growth
4.6 Middle East & Africa Pharmaceuticals Plant Protein Sales Growth
5 Americas
5.1 Americas Pharmaceuticals Plant Protein Sales by Country
5.1.1 Americas Pharmaceuticals Plant Protein Sales by Country (2019-2024)
5.1.2 Americas Pharmaceuticals Plant Protein Revenue by Country (2019-2024)
5.2 Americas Pharmaceuticals Plant Protein Sales by Type (2019-2024)
5.3 Americas Pharmaceuticals Plant Protein Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceuticals Plant Protein Sales by Region
6.1.1 APAC Pharmaceuticals Plant Protein Sales by Region (2019-2024)
6.1.2 APAC Pharmaceuticals Plant Protein Revenue by Region (2019-2024)
6.2 APAC Pharmaceuticals Plant Protein Sales by Type (2019-2024)
6.3 APAC Pharmaceuticals Plant Protein Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceuticals Plant Protein by Country
7.1.1 Europe Pharmaceuticals Plant Protein Sales by Country (2019-2024)
7.1.2 Europe Pharmaceuticals Plant Protein Revenue by Country (2019-2024)
7.2 Europe Pharmaceuticals Plant Protein Sales by Type (2019-2024)
7.3 Europe Pharmaceuticals Plant Protein Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceuticals Plant Protein by Country
8.1.1 Middle East & Africa Pharmaceuticals Plant Protein Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pharmaceuticals Plant Protein Revenue by Country (2019-2024)
8.2 Middle East & Africa Pharmaceuticals Plant Protein Sales by Type (2019-2024)
8.3 Middle East & Africa Pharmaceuticals Plant Protein Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceuticals Plant Protein
10.3 Manufacturing Process Analysis of Pharmaceuticals Plant Protein
10.4 Industry Chain Structure of Pharmaceuticals Plant Protein
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceuticals Plant Protein Distributors
11.3 Pharmaceuticals Plant Protein Customer
12 World Forecast Review for Pharmaceuticals Plant Protein by Geographic Region
12.1 Global Pharmaceuticals Plant Protein Market Size Forecast by Region
12.1.1 Global Pharmaceuticals Plant Protein Forecast by Region (2025-2030)
12.1.2 Global Pharmaceuticals Plant Protein Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Pharmaceuticals Plant Protein Forecast by Type (2025-2030)
12.7 Global Pharmaceuticals Plant Protein Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 ADM
13.1.1 ADM Company Information
13.1.2 ADM Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.1.3 ADM Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 ADM Main Business Overview
13.1.5 ADM Latest Developments
13.2 Cargill
13.2.1 Cargill Company Information
13.2.2 Cargill Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.2.3 Cargill Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Cargill Main Business Overview
13.2.5 Cargill Latest Developments
13.3 DuPont
13.3.1 DuPont Company Information
13.3.2 DuPont Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.3.3 DuPont Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 DuPont Main Business Overview
13.3.5 DuPont Latest Developments
13.4 Kerry Group
13.4.1 Kerry Group Company Information
13.4.2 Kerry Group Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.4.3 Kerry Group Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Kerry Group Main Business Overview
13.4.5 Kerry Group Latest Developments
13.5 Manildra
13.5.1 Manildra Company Information
13.5.2 Manildra Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.5.3 Manildra Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Manildra Main Business Overview
13.5.5 Manildra Latest Developments
13.6 Roquette
13.6.1 Roquette Company Information
13.6.2 Roquette Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.6.3 Roquette Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Roquette Main Business Overview
13.6.5 Roquette Latest Developments
13.7 Tereos
13.7.1 Tereos Company Information
13.7.2 Tereos Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.7.3 Tereos Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Tereos Main Business Overview
13.7.5 Tereos Latest Developments
13.8 Axiom Foods
13.8.1 Axiom Foods Company Information
13.8.2 Axiom Foods Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.8.3 Axiom Foods Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Axiom Foods Main Business Overview
13.8.5 Axiom Foods Latest Developments
13.9 Cosucra
13.9.1 Cosucra Company Information
13.9.2 Cosucra Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.9.3 Cosucra Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Cosucra Main Business Overview
13.9.5 Cosucra Latest Developments
13.10 CHS
13.10.1 CHS Company Information
13.10.2 CHS Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.10.3 CHS Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CHS Main Business Overview
13.10.5 CHS Latest Developments
13.11 Glanbia Nutritionals
13.11.1 Glanbia Nutritionals Company Information
13.11.2 Glanbia Nutritionals Pharmaceuticals Plant Protein Product Portfolios and Specifications
13.11.3 Glanbia Nutritionals Pharmaceuticals Plant Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Glanbia Nutritionals Main Business Overview
13.11.5 Glanbia Nutritionals Latest Developments
14 Research Findings and Conclusion